ProShares Ultra NASDAQ Biotechnology
25 hedge funds and large institutions have $8.16M invested in ProShares Ultra NASDAQ Biotechnology in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 7 increasing their positions, 8 reducing their positions, and 0 closing their positions.
Holders
25
Holders Change
+1
Holders Change %
+4.17%
% of All Funds
0.39%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
7
Reduced
8
Closed
–
Calls
$1.6M
Puts
$1.42M
Net Calls
+$187K
Net Calls Change
-$116K